Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Hansen

Showing results (811-820 of 888) with videos related to

Pageof 89
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2016
Allogeneic T Cells That Express an Anti-CD19 Chimeric Antigen Receptor Induce Remissions of B-Cell Malignancies That Progress After Allogeneic Hematopoietic Stem-Cell Transplantation Without Causing Graft-Versus-Host DiseaseJennifer N Brudno, Robert P T Somerville, Victoria Shi, et al.
Plos Pathogens|April 19, 2023
Correction: Mitigation of endemic GI-tract pathogen-mediated inflammation through development of multimodal treatment regimen and its impact on SIV acquisition in rhesus macaquesRachele M Bochart, Kathleen Busman-Sahay, Stephen Bondoc, et al.
Nature Communications|October 5, 2023
The USP46 complex deubiquitylates LRP6 to promote Wnt/β-catenin signalingVictoria H Ng, Zachary Spencer, Leif R Neitzel, et al.
Nature Communications|October 29, 2025
scRNA-seq reveals persistent aberrant differentiation of nasal epithelium driven by TNFα and TGFβ in post-COVID syndromeK D Reddy, Y Maluje, F Ott, et al.
JCI Insight|February 7, 2023
Late gene expression-deficient cytomegalovirus vectors elicit conventional T cells that do not protect against SIVScott G Hansen, Jennie L Womack, Wilma Perez, et al.
Science (New York, N.Y.)|March 26, 2021
Modulation of MHC-E transport by viral decoy ligands is required for RhCMV/SIV vaccine efficacyMarieke C Verweij, Scott G Hansen, Ravi Iyer, et al.
Nature Medicine|August 8, 2018
Early antiretroviral therapy limits SIV reservoir establishment to delay or prevent post-treatment viral reboundAfam A Okoye, Scott G Hansen, Mukta Vaidya, et al.
Frontiers in Immunology|August 27, 2025
An immune-focused supplemental alignment pipeline captures information missed from dominant single-cell RNA-seq analyses, including allele-specific MHC-I regulationSebastian Benjamin, G W McElfresh, Maanasa Kaza, et al.
Nature|September 13, 2013
Immune clearance of highly pathogenic SIV infectionScott G Hansen, Michael Piatak, Abigail B Ventura, et al.
Science (New York, N.Y.)|May 25, 2013
Cytomegalovirus vectors violate CD8+ T cell epitope recognition paradigmsScott G Hansen, Jonah B Sacha, Colette M Hughes, et al.
Pageof 89

Showing results (811-820 of 888) with videos related to

Sort By:
Pageof 89
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2016
Allogeneic T Cells That Express an Anti-CD19 Chimeric Antigen Receptor Induce Remissions of B-Cell Malignancies That Progress After Allogeneic Hematopoietic Stem-Cell Transplantation Without Causing Graft-Versus-Host DiseaseJennifer N Brudno, Robert P T Somerville, Victoria Shi, et al.
Plos Pathogens|April 19, 2023
Correction: Mitigation of endemic GI-tract pathogen-mediated inflammation through development of multimodal treatment regimen and its impact on SIV acquisition in rhesus macaquesRachele M Bochart, Kathleen Busman-Sahay, Stephen Bondoc, et al.
Nature Communications|October 5, 2023
The USP46 complex deubiquitylates LRP6 to promote Wnt/β-catenin signalingVictoria H Ng, Zachary Spencer, Leif R Neitzel, et al.
Nature Communications|October 29, 2025
scRNA-seq reveals persistent aberrant differentiation of nasal epithelium driven by TNFα and TGFβ in post-COVID syndromeK D Reddy, Y Maluje, F Ott, et al.
JCI Insight|February 7, 2023
Late gene expression-deficient cytomegalovirus vectors elicit conventional T cells that do not protect against SIVScott G Hansen, Jennie L Womack, Wilma Perez, et al.
Science (New York, N.Y.)|March 26, 2021
Modulation of MHC-E transport by viral decoy ligands is required for RhCMV/SIV vaccine efficacyMarieke C Verweij, Scott G Hansen, Ravi Iyer, et al.
Nature Medicine|August 8, 2018
Early antiretroviral therapy limits SIV reservoir establishment to delay or prevent post-treatment viral reboundAfam A Okoye, Scott G Hansen, Mukta Vaidya, et al.
Frontiers in Immunology|August 27, 2025
An immune-focused supplemental alignment pipeline captures information missed from dominant single-cell RNA-seq analyses, including allele-specific MHC-I regulationSebastian Benjamin, G W McElfresh, Maanasa Kaza, et al.
Nature|September 13, 2013
Immune clearance of highly pathogenic SIV infectionScott G Hansen, Michael Piatak, Abigail B Ventura, et al.
Science (New York, N.Y.)|May 25, 2013
Cytomegalovirus vectors violate CD8+ T cell epitope recognition paradigmsScott G Hansen, Jonah B Sacha, Colette M Hughes, et al.
Pageof 89